USPTO serial 79358529
MEDIX BIOCHEMICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 7, 2025
- Examiner
- BODRI, KRISTIN MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MEDIX BIOCHEMICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for use in scientific and medical research; diagnostic preparations for medical research; reagent media for medical research; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for scientific or research use; antibodies for use in scientific and medical research in the nature of mononuclean antibodies; assays for research purposes; buffer solutions for use in analytical chemistry; control reagents for research purposes for use with scientific apparatus and instruments; protein labelling kits comprising reagents for use in scientific and medical research; assay kits consisting of chemical reagents for scientific and medical research; assay kits consisting of biological reagents for scientific and medical research; protein in raw material form for scientific and medical research; proteins in raw material form for scientific and medical research for detecting antibodies; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; chemicals for use in biotechnological manufacturing processes and product development; nucleotides for scientific and research use; proteins for use in manufacture; reagent medium for medical research | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; medical diagnostic reagents; veterinary diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for diagnostic purposes; monoclonal antibodies for medical and diagnostic use; pregnancy and fertility test kits for home and medical use; medical diagnostic test strips for home and medical use for use in the fields of immunology, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics and oncology; diagnostic preparations for medical use; reagent media for medical diagnostic purposes; medical immunological diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer; monoclonal antibodies for use in disease testing; leukocyte antibodies for use in disease testing; cytokines and chemokines for use in disease testing; adhesion molecules for use in disease testing; endothelial cells for medical use; progenitor cells for medical use; medical diagnostic reagents and assays for detecting apoptosis; medical diagnostic reagents for cellular transduction; stem cells for medical use | ACTIVE | — |
| 010 | Medical testing devices utilizing immunological methods, in the form of kits primarily comprised of test strips capable of visual or instrument read out of test results, buffer tubes, medical specimen collection loops and vials, for use in testing of blood, plasma, serum, and other bodily fluids, and also including cotton swabs and pads for medical purposes; medical diagnostic instruments for in vitro diagnostic testing and in vitro analysis utilizing immunological methods for use in the field of immunology, anesthesia, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics, radiology, radiation, oncology, and surgery; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for medical use for use in in vitro diagnostic testing procedures, cardiovascular diagnosis and screening, diabetes monitoring and diagnosis, pregnancy monitoring, monitoring and diagnosing metabolic functions, detecting, screening and monitoring infectious diseases, inflammatory diseases, skin disorders, thyroid diseases and cancer; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for blood analysis, urine analysis, fecal analysis, saliva analysis, analysis of oral fluids, analysis of amniotic fluids, analysis of cervicospinal fluid, analysis of ascites, analysis of pleural fluids, analysis of exudate, analysis of cervical, vaginal and cervico-vaginal secretions; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use comprised of collection pads or swabs, collection loops or vials, test strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for analysing oral fluid, urine, feces, amniotic fluid, vaginal secretions, cervical secretions, cervico-vaginal secretions, finger stick or venipuncture whole blood, plasma, serum, exudate, skin, cervicospinal fluid, ascites, pleural fluids, other bodily fluids and specimens; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for use in detecting antibodies, antigen, viruses, bacteria and other pathogens, disease markers and metabolites, fecal occult blood, hormones, vitamins, proteins, nucleic acids, toxins, drugs and their metabolites, drugs of abuse and chemicals | ACTIVE | — |
| 040 | Manufacturing of diagnostic preparations and reagent medium to order for medical use and medical research and non-medical purposes; manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, diagnostics, health care products and medical products; treatment of materials, namely, pharmaceutical, diagnostic and chemical products and their components used in the manufacture of pharmaceuticals, biopharmaceuticals, diagnostic preparations, reagent media, test kits, testing apparatus and instruments; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, diagnostic preparations and reagent medium | ACTIVE | — |
| 042 | Medical and scientific research; pharmaceutical research and development; development of antibodies for others; antibody research and development services; development of assays for diagnostic purposes; medical laboratories; conducting clinical trials; scientific research consulting services in the field of medical and health care technology; medical and pharmacological research; providing of information and data relating to medical research and development; product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; monoclonal antibody research and development services | ACTIVE | — |
| 044 | Providing medical information, consultation and advisory services; medical consulting services in the field of diagnostics; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; providing medical information through a website; medical diagnostic testing and reporting services; tissue typing services in the nature of blood testing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MEDIX BIOCHEMICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 12, 2025 | IRFI | IRREGULARITY ON FINAL DECISION RECEIVED FROM IB | — |
| Jul 2, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 2, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 7, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 10, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 28, 2024 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Mar 28, 2024 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 28, 2024 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 29, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 29, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 29, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2023 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 13, 2023 | PBSR | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | — |
| Mar 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 23, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |